Editorial Board: Arch Pharm (4/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 4, p. 1, doi. 10.1002/ardp.202270009
- Publication type:
- Article
Works matching IS 03656233 AND DT 2022 AND VI 355 AND IP 4
Results: 14
1
2
Cover Picture: Arch Pharm (4/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 4, p. 1, doi. 10.1002/ardp.202270008
- Publication type:
- Article
3
Erratum: First‐in‐class pyrido[2,3‐d]pyrimidine‐2,4(1H,3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
4
Comparative analysis of apocarotenoids and phenolic constituents of Crocus sativus stigmas from 11 countries: Ecological impact.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 4, p. 1, doi. 10.1002/ardp.202100468
- By:
- Publication type:
- Article
5
Absolute configuration of cytotoxic anthraquinones from a Brazilian cave soil‐derived fungus, Aspergillus sp. SDC28.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 4, p. 1, doi. 10.1002/ardp.202100441
- By:
- Publication type:
- Article
6
Antibacterial and anticancer profiling of new benzocaine derivatives: Design, synthesis, and molecular mechanism of action.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 4, p. 1, doi. 10.1002/ardp.202100451
- By:
- Publication type:
- Article
7
First‐in‐class pyrido[2,3‐d]pyrimidine‐2,4(1H,3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 4, p. 1, doi. 10.1002/ardp.202100440
- By:
- Publication type:
- Article
8
Risk assessment for nitrosated pharmaceuticals: A future perspective in drug development.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 4, p. 1, doi. 10.1002/ardp.202100435
- By:
- Publication type:
- Article
9
Synthesis, characterization, and biological evaluation of some novel Schiff bases as potential metabolic enzyme inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 4, p. 1, doi. 10.1002/ardp.202100430
- By:
- Publication type:
- Article
10
Linked biaromatic compounds as cardioprotective agents.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 4, p. 1, doi. 10.1002/ardp.202100428
- Publication type:
- Article
11
Green synthesis of pregabalin‐stabilized gold nanoclusters and their applications in sensing and drug release.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 4, p. 1, doi. 10.1002/ardp.202100426
- By:
- Publication type:
- Article
12
Design, synthesis, in silico ADMET, docking, and antiproliferative evaluations of [1,2,4]triazolo[4,3‐c]quinazolines as classical DNA intercalators.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 4, p. 1, doi. 10.1002/ardp.202100412
- By:
- Publication type:
- Article
13
Potential of triazines in Alzheimer's disease: A versatile privileged scaffold.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 4, p. 1, doi. 10.1002/ardp.202100388
- By:
- Publication type:
- Article
14
Up‐to‐date studies regarding the determination of melatonin by chromatographic methods.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 4, p. 1, doi. 10.1002/ardp.202100378
- By:
- Publication type:
- Article